TUCCI, MARCO GAETANO
 Distribuzione geografica
Continente #
NA - Nord America 8.232
AS - Asia 3.578
EU - Europa 2.553
SA - Sud America 884
AF - Africa 117
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 15.373
Nazione #
US - Stati Uniti d'America 8.102
SG - Singapore 1.569
CN - Cina 794
BR - Brasile 747
HK - Hong Kong 559
SE - Svezia 505
RU - Federazione Russa 435
IT - Italia 396
DE - Germania 308
VN - Vietnam 253
GB - Regno Unito 199
UA - Ucraina 189
FI - Finlandia 148
FR - Francia 106
ID - Indonesia 88
CA - Canada 75
IN - India 73
AR - Argentina 58
PL - Polonia 47
BE - Belgio 42
BD - Bangladesh 39
CI - Costa d'Avorio 39
AT - Austria 35
MX - Messico 33
JP - Giappone 32
ZA - Sudafrica 30
NL - Olanda 29
IQ - Iraq 26
LT - Lituania 20
EC - Ecuador 19
IE - Irlanda 19
TR - Turchia 18
ES - Italia 17
MA - Marocco 16
CO - Colombia 14
PK - Pakistan 14
SA - Arabia Saudita 14
VE - Venezuela 14
CL - Cile 13
IR - Iran 12
UZ - Uzbekistan 10
JO - Giordania 9
KE - Kenya 9
PY - Paraguay 9
AL - Albania 8
KR - Corea 8
NP - Nepal 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
TN - Tunisia 6
AU - Australia 5
CH - Svizzera 5
CR - Costa Rica 5
GR - Grecia 5
MK - Macedonia 5
PE - Perù 5
RO - Romania 5
BG - Bulgaria 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
EG - Egitto 4
JM - Giamaica 4
MY - Malesia 4
OM - Oman 4
PH - Filippine 4
HN - Honduras 3
HR - Croazia 3
HU - Ungheria 3
IL - Israele 3
KG - Kirghizistan 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
UY - Uruguay 3
AM - Armenia 2
BY - Bielorussia 2
DZ - Algeria 2
EE - Estonia 2
GT - Guatemala 2
IS - Islanda 2
LB - Libano 2
MN - Mongolia 2
PT - Portogallo 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BM - Bermuda 1
BO - Bolivia 1
BW - Botswana 1
CD - Congo 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
LK - Sri Lanka 1
Totale 15.359
Città #
Fairfield 930
Ashburn 878
Singapore 815
Chandler 699
Woodbridge 634
Hong Kong 552
Jacksonville 427
Houston 416
Nyköping 407
Seattle 369
Cambridge 361
Beijing 308
Wilmington 300
Ann Arbor 269
Lawrence 151
Roxbury 148
New York 135
Dallas 123
Los Angeles 122
Nanjing 114
Des Moines 95
Bari 85
Princeton 76
Ho Chi Minh City 75
Jakarta 72
Santa Clara 72
São Paulo 72
Inglewood 61
Boardman 60
Munich 59
Brooklyn 57
Buffalo 51
San Diego 48
Helsinki 46
Hanoi 45
Warsaw 45
Chicago 44
Brussels 42
Nuremberg 40
Abidjan 39
London 35
Redwood City 33
Paris 32
Dong Ket 31
Falkenstein 30
North Bergen 26
Shenyang 26
Council Bluffs 24
Frankfurt am Main 24
Hebei 23
Nanchang 23
Tokyo 22
Dearborn 20
Stockholm 20
Belo Horizonte 19
Denver 19
Dublin 19
Rio de Janeiro 19
Toronto 19
Chennai 17
Johannesburg 17
Milan 17
Montreal 17
Moscow 17
Rome 17
Vienna 17
Phoenix 16
Amsterdam 15
Columbus 15
Salt Lake City 15
San Jose 15
The Dalles 15
Tianjin 15
San Mateo 14
Guangzhou 13
Mumbai 13
Ottawa 13
Poplar 13
Taranto 13
Jiaxing 12
Arzano 11
Atlanta 11
Boston 11
Brasília 11
Changsha 11
Da Nang 11
Düsseldorf 11
Lauterbourg 11
Marseille 11
Mexico City 11
Porto Alegre 11
Turku 11
Washington 11
Dhaka 10
Manchester 10
Orem 10
San Francisco 10
Augusta 9
Baghdad 9
Curitiba 9
Totale 10.332
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). 258
Animal-type melanoma: Dog or wolf? A review of the literature and a case report 184
Cilengitide restrains the osteoclast-like bone resorbing activity of myeloma plasma cells. 172
Adenocarcinoma of the ceruminous glands: role of the VMAT 167
Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis 163
Exosomes in melanoma: A role in tumor progression, metastasis and impaired immune system activity 160
The metabolic milieu in melanoma: Role of immune suppression by CD73/adenosine 158
Tumor-derived exosomes promote the in vitro osteotropism of melanoma cells by activating the SDF-1/CXCR4/CXCR7 axis. 156
The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma. 153
Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology 151
Avβ3 integrin: Pathogenetic role in osteotropic tumors 151
Defective levels of both circulating dendritic cells and T-regulatory cells correlate with risk of recurrence in cutaneous melanoma 151
Everolimus restrains the paracrine pro-osteoclast activity of breast cancer cells 149
Cancer treatment-induced bone loss (CTIBL): Pathogenesis and clinical implications. 148
Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression 148
Immune system and melanoma biology: A balance between immunosurveillance and immune escape 147
The Tumor Microenvironment in Neuroendocrine Tumors: Biology and Therapeutic Implications 144
Dissection of major cancer gene variants in subsets of circulating tumor cells in advanced breast cancer. 142
Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations 141
Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells. 140
Everolimus restrains the IL-17A-dependent osteoclast-like transdifferentiation of dendritic cells in multiple myeloma 139
Dual-procedural separation of CTCs in cutaneous melanoma provides useful information for both molecular diagnosis and prognosis 138
Up-regulation of IL-18 and predominance of a Th1 immune response is a hallmark of lupus nephritis 134
The Role of Cytotoxic Chemotherapy in Well-Differentiated Gastroenteropancreatic and Lung Neuroendocrine Tumors. 133
Cytotherapies in multiple myeloma: a complementary approach to current treatments 132
PTHrP produced by myeloma plasma cells regulates their survival and pro-osteoclast activity for bone disease progression. 131
CORRIGENDUM to The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma 130
Anemia in multiple myeloma: role of deregulated plasma cell apoptosis 129
Lenalidomide exerts cytostatic activity on melanoma cells by negative regulation of their cell cycle 125
Cytokine Overproduction, T-Cell Activation, and Defective T-Regulatory Functions Promote Nephritis in Systemic Lupus Erythematosus 124
Does cilengitide deserve another chance? 124
Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitors 124
Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis 123
An imbalance between Beclin-1 and p62 expression promotes the proliferation of myeloma cells through autophagy regulation. 123
The clonal heterogenicity of circulating tumor cells (CTCs) drives their metastatic potential: a new NOD‐SCID melanoma model 122
A peculiar molecular profile of umbilical cord-mesenchymal stromal cells drives their inhibitory effects on multiple myeloma cell growth and tumor progression. 121
Recent advances in understanding the pathogenesis of anemia in multiple myeloma 118
Upregulation of osteoblast apoptosis by malignant plasma cells: a role in myeloma bone disease 118
Revisiting the Role of Exosomes in Colorectal Cancer: Where Are We Now? 117
Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma 115
AlphaVBeta3+ (AvB3) adhesion molecule drives the osteoclast (OC)-like functional differentiation of myeloma cells (MC) 112
Immature dendritic cells from patients with multiple myeloma are prone to osteoclast differentiation in vitro 111
Enhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95/Apo-I) in active lupus 108
The density and spatial tissue distribution of CD8+ and CD163+ immune cells predict response and outcome in melanoma patients receiving MAPK inhibitors. 107
Antiphosphatidylserine antibodies in human immunodeficiency virus-1 patients with evidence of T-cell apoptosis and mediate antibody-dependent cellular cytotoxicity 106
Negative regulation of erythroblast maturation by Fas-L+/TRAIL(+) highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma 106
An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival 106
The day after mass COVID-19 vaccination: incidence of vaccine-related lymphadenopathy PET and impact on oncologic patients management 104
null 103
A functional polymorphism in the monocyte chemoattractant protein (MCP)-1 promoter gene is strongly associated with lupus nephritis 102
A new tool for the evaluation of disease activity in lupus nephritis: Urinary monocyte chemoattractant protein (MCP)-1. 102
A functional polymorphism in the monocyte chemoattractant protein (MCP) - 1 promoter gene is strongly associated with lupus nephritis 102
Alpha(V)Beta(3) (alpha(v)beta(3)) integrin drives the osteoclastogenesis through a osteoclast-like functional differentiation of myeloma cells 101
Nef protein induces differential effects in CD8+ cells from HIV-1-infected patients 101
[Malignant neoplasms and AIDS. Review of the literature and critical considerations on a case of epidermoid carcinoma of the anus]. FT Neoplasie maligne e AIDS. Rassegna della letteratura e considerazioni critiche su un caso di carcinoma epidermoide dell'ano. 100
SNPs in predicting clinical efficacy and toxicity of chemotherapy: Walking through the quicksand 100
Antiphosphatidylserine antibodies in human immunodeficiency virus-1(+) patients correlate with evidence of T-cell apoptosis and mediate antibody-dependent cellular cytotoxicity 100
The immune escape in melanoma: role of the impaired dendritic cell function 99
Induction of apoptosis by the hydrocarbon oil pristane: Implications for pristane-induced lupus 99
A role for fas-ligand in the pathogenesis and progression of multiple myeloma(MM). 98
Immature dendritic cells in multiple myeloma are prone to osteoclast-like differentiation through interleukin-17A stimulation 98
Erratum for Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). 98
DLC-1 down-regulation via exosomal miR-106b-3p exchange promotes CRC metastasis by the epithelial-to-mesenchymal transition 98
Large extracellular vesicles—a new frontier of liquid biopsy in oncology 97
miRNAs in melanoma: a defined role in tumor progression and metastasis 96
Fas-L up-regulation by highly malignant myeloma plasma cells: role in the pathogenesis of anemia and disease progression 94
Liquid Biopsy as a Tool Exploring in Real-Time Both Genomic Perturbation and Resistance to EGFR Antagonists in Colorectal Cancer 94
Natural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis survey. 94
Effect of vitaxin on hyperactive osteoclastogenesis in multiple myeloma: a preclinical study 93
Increased IL-18 production by dendritic cells in active inflammatory myopathies 92
Alphavbeta3 (AVB3) adhesion molecule drives the osteoclast (OC)-like functional differentiation of myeloma cells (MC) 92
Role of Bone Targeting Agents in the Prevention of Bone Metastases from Breast Cancer 92
Overexpression of Fas antigen on T cells in advanced HIV-1 infection: differential ligation constantly induces apoptosis 91
Bone Metastases in Neuroendocrine Tumors: Molecular Pathogenesis and Implications in Clinical Practice 90
Severe anemia in a patient with vulvar melanoma 90
Successful treatment with apremilast of severe psoriasis exacerbation during nivolumab therapy for metastatic melanoma 90
Is measurement of IL-10 useful for disease management in SLE? 89
The ATM Gene in Breast Cancer: Its Relevance in Clinical Practice 89
Functional Fas-ligand expression on T cells from HIV-1-infected patients is unrelated to CD4+ lymphopenia 88
The interplay of chemokines and dendritic cells in the pathogenesis of lupus nephritis 88
In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells 87
Dendritic Cells and Malignant Plasma Cells: An Alliance in Multiple Myeloma Tumor Progression? 87
Th1 cytokines in the pathogenesis of lupus nephritis: The role of IL-18 87
Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patients. 87
Combination of immunotherapy and other targeted therapies in advanced cutaneous melanoma 87
Deregulated expression of monocyte chemoattractant protein-1 (MCP-1) in arterial hypertension: role in endothelial inflammation and atheromasia 86
L'eritropoietina umana nel trattamento dell'anemia associata al mieloma multiplo: potenziale effetto mitogeno sui linfociti B 85
VEINCTR-N, an immunogenic epitope of Fas (CD95/Apo-I), and soluble Fas enhance T-cell apoptosis in vitro. II. Functional analysis and possible implications in HIV-1 disease 85
Bone-Resorbing Cells in Multiple Myeloma: Osteoclasts, Myeloma Cell Polykaryons, or Both? 85
null 85
Massive hyper-progression during anti-PD1 immunotherapy in a young patient with metastatic mucinous adenocarcinoma of the right colon: a case report and literature review 85
Biliary tract cancers: moving from the present standards of care towards the use of immune checkpoint inhibitors 82
Urinary biomarkers in lupus nephritis 81
Characterization of the metastatic behavior and gene expression profile (RNAseq) of different melanoma cell lines: a comprehensive in vivo model. 81
Bone metastases in soft tissue sarcoma patients: a survey of natural, prognostic value and treatment 79
null 78
The DOG1 scoring system in GIST: a novel factor for measurement of the recurrence risk 78
Immune escape of multiple myeloma cells results from low miR29b and the ensuing epigenetic silencing of proteasome genes 76
Vasculiti primarie sistemiche 76
In search of a bone metastasis (BM) gene signature in circulating tumour cells (CTCs) from stage IV breast cancer (BC) patients 76
Totale 11.276
Categoria #
all - tutte 77.207
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.207


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.049 0 0 0 0 0 144 225 148 119 192 120 101
2021/20221.108 63 139 16 57 55 80 37 53 75 83 193 257
2022/20231.888 284 222 124 159 193 253 37 231 297 17 45 26
2023/2024680 62 127 41 102 64 114 20 33 9 18 15 75
2024/20253.310 134 38 285 160 95 271 336 288 172 216 427 888
2025/20263.745 1.055 341 448 776 801 324 0 0 0 0 0 0
Totale 15.998